|
US2020054626A1
|
|
Methylnaltrexone nasal formulations, methods of making, and use thereof
|
|
US2018092837A1
|
|
Antihistamine compositions, combinations, and use thereof
|
|
US2016120811A1
|
|
Methods of administering antihistamines
|
|
WO2011078993A1
|
|
Functionally-coated multilayer tablets
|
|
WO2011025673A1
|
|
Multilayer minitablets
|
|
WO2011005686A1
|
|
Self-breaking tablets
|
|
WO2010138439A1
|
|
Multiparticulate controlled-release selective serotonin reuptake inhibitor formulations
|
|
WO2010138441A1
|
|
Multilayer oral tablets containing a non-steroidal anti-inflammatory drug and/or acetaminophen
|
|
WO2010014502A1
|
|
Functionally coated breakable tablets
|
|
WO2009137648A1
|
|
Multilayer proton pump inhibitor tablets
|
